- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07610785
Standardized Adaptive Music Medicine for Suicidality (STAMM-S)
May 20, 2026 updated by: Daniel Bowling, Stanford University
The primary goal of this clinical trial is to test if music-based intervention (STAMM-S) works for individuals with suicidal thoughts or behaviors. The main questions it aims to answer are:
- Can implementing specific music to listen to for 20 minutes a day for 25 days improve suicidality?
- Can implementing education around the psychology of the medicine of music improve mental health outcomes?
Participants will:
- Listen to music given to them by the study team for 20 minutes a day for 25 days
- Receive musical psychoeducation on how to improve mood using music
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Yuukis Hall - Stanford University
-
Principal Investigator:
- Daniel L Bowling, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 14-35 years
- Suicidal ideation (C-SSRS categories 1-3 within the past month)
- normal sensitivity to music reward on the Barcelona Music Reward Questionnaire. Score >65
Exclusion Criteria:
- imminent or acute suicide risk (C-SSRS categories 4-5).
- Co-morbid substance use disorder.
- Co-morbid psychotic disorder.
- current participation in another trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: STAMM-S
Participants receive musical psychoeducation and take a dose of 20 minutes of adaptive music per day for 25 days.
|
Participants will undergo the STAMM-S treatment, which involves music generated using machine learning to move to a more positive affect.
They will also receive education on how to best use the music assigned to improve their mood.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Suicidality via Beck Scale for Suicidal Ideation (BSS/BSSI) Score
Time Frame: Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
A 19-item scale with each item scoring from 0-2 rating an individual's suicidal thoughts, intent, and ideation.
The total score ranges from 0 to 38.
A higher score indicates more intense suicidal ideation and a low score indicates less intense suicidal ideation.
|
Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
|
Change in Generalized Anxiety Disorder Status via Generalized Anxiety Disorder-7 (GAD-7) Score
Time Frame: Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
A 7-item measure scaled 0-3 per item that measures symptoms of Generalized Anxiety Disorder.
0 would be no sign of anxiety and 3 would indicate high level of anxiety over the last two weeks.
|
Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
|
Change in Depression Status via Patient Health Questionnaire-9 (PHQ-9) Score
Time Frame: Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
A 9-item questionnaire that measures symptoms of depression on a 0-3 scale over the last two weeks.
0 would indicate "not at all", 1 would indicate "several days", 2 would indicate "most of the days", and a 3 would indicate "nearly every day".
|
Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Music Listening Purpose via Healthy-Unhealthy Music Scale (HUMS) - Healthy Score
Time Frame: Baseline, end of study (up to 25 days).
|
Participants respond to a 5-question survey.
The scale ranges from 5 to 25.
For the healthy scale, a higher rating means a healthier use of music.
|
Baseline, end of study (up to 25 days).
|
|
Change in Music Listening Purpose via Healthy-Unhealthy Music Scale (HUMS) - Unhealthy Score
Time Frame: Baseline, end of study (up to 25 days).
|
Participants respond to an 8-question survey.
The scale ranges 8 to 40.
A higher rating for the unhealthy scale indicates a more maladaptive use of music.
|
Baseline, end of study (up to 25 days).
|
|
Acceptability Scale Score
Time Frame: At the end of the intervention (25 days after enrollment).
|
A 7-question questionnaire on a scale of 0-7 covering the 7 core components on intervention acceptability, where a 0 would indicate total unacceptability and 7 would equal total acceptability.
Single participant rating of 4 or greater will be interpreted as satisfactory acceptability.
|
At the end of the intervention (25 days after enrollment).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Daniel L. Bowling, PhD, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
May 1, 2027
Study Registration Dates
First Submitted
May 20, 2026
First Submitted That Met QC Criteria
May 20, 2026
First Posted (Actual)
May 28, 2026
Study Record Updates
Last Update Posted (Actual)
May 28, 2026
Last Update Submitted That Met QC Criteria
May 20, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 86501
- ECR-0-025-24 (Other Grant/Funding Number: American Foundation for Suicide Prevention)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.